NSC |
Compound |
Enrichment |
Correlation |
NSC 163443 |
Null |
0.0396077140933377 |
0.1413321 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.0396077140933377 |
0.25276933 |
NSC 244404 |
Null |
0.0396077140933377 |
0.3513192 |
NSC 3077 |
s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) |
0.0396077140933377 |
-0.11058535 |
NSC 30915 |
Null |
0.0396077140933377 |
0.64637393 |
NSC 351521 |
Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) |
0.0396077140933377 |
0.3294568 |
NSC 39215 |
Null |
0.0396077140933377 |
0.56590627 |
NSC 601518 |
Null |
0.0396077140933377 |
0.68902958 |
NSC 614887 |
Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) |
0.0396077140933377 |
0.57503513 |
NSC 624657 |
ANTINEOPLASTIC-624657 |
0.0396077140933377 |
0.37888765 |